Atrion (ATRI) Short Interest Ratio & Short Volume → Wall Street Legend Warns: 'A Strange Day Is Coming to America' (From Chaikin Analytics) (Ad) Free ATRI Stock Alerts $456.05 -6.88 (-1.49%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Atrion Short Interest DataCurrent Short Interest129,200 sharesPrevious Short Interest120,500 sharesChange Vs. Previous Month+7.22%Dollar Volume Sold Short$64.08 millionShort Interest Ratio4.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares1,760,000 sharesFloat Size1,360,000 sharesShort Percent of Float9.50%Today's Trading Volume72,539 sharesAverage Trading Volume21,204 sharesToday's Volume Vs. Average342% Short Selling Atrion ? Sign up to receive the latest short interest report for Atrion and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATRI Short Interest Over TimeATRI Days to Cover Over TimeATRI Percentage of Float Shorted Over Time Ad The TradingPubLook what happened to Netflix during these “Hotspot Dates”We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… Atrion Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024129,200 shares $64.08 million +7.2%9.5%4.7 $495.99 4/30/2024120,500 shares $51.01 million +0.8%8.9%5.3 $423.29 4/15/2024119,500 shares $47.64 million +22.3%8.7%6.4 $398.68 3/31/202497,700 shares $45.29 million +4.7%7.1%6.5 $463.55 3/15/202493,300 shares $40.69 million +40.9%6.8%7.3 $436.10 2/29/202466,200 shares $24.36 million +3.3%4.8%6.2 $367.99 Get the Latest News and Ratings for ATRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter. 2/15/202464,100 shares $22.68 million -3.6%4.7%6.9 $353.80 1/31/202466,500 shares $22.61 million +14.7%4.9%7 $340.00 1/15/202458,000 shares $20.36 million +3.2%4.2%6.2 $350.99 12/31/202356,200 shares $21.29 million +43.7%4.1%6.3 $378.79 12/15/202339,100 shares $14.22 million -0.3%2.9%5 $363.66 11/30/202339,200 shares $12.09 million +1.6%2.9%6.4 $308.35 11/15/202338,600 shares $11.17 million -3.7%2.8%7.3 $289.29 10/31/202340,100 shares $13.71 million -8.5%3.0%8.7 $341.98 10/15/202343,800 shares $17.49 million +6.6%3.3%10.7 $399.30 9/30/202341,100 shares $16.98 million +0.7%3.1%11.7 $413.17 9/15/202340,800 shares $18.77 million -1.5%3.0%12.4 $460.00 8/31/202341,400 shares $19.26 million -3.5%3.1%12.2 $465.10 8/15/202342,900 shares $21.71 million -0.9%3.2%11.6 $506.02 7/31/202343,300 shares $24.27 million +4.6%3.2%11.1 $560.61 7/15/202341,400 shares $22.77 million +1.7%3.1%10.6 $549.90 6/30/202340,700 shares $23.02 million -1.9%3.0%10.4 $565.70 6/15/202341,500 shares $22.00 million +28.1%3.1%10.4 $530.20 5/31/202332,400 shares $16.86 million -5.3%2.4%8.8 $520.36 5/15/202334,200 shares $19.36 million -3.7%2.6%9 $566.11 4/30/202335,500 shares $21.84 million -8.3%2.7%9.3 $615.30 4/15/202338,700 shares $24.95 million -2.0%2.9%9.9 $644.78 3/31/202339,500 shares $24.80 million -7.9%3.0%9.9 $627.91 3/15/202342,900 shares $25.48 million +4.4%3.2%10.5 $594.01 2/28/202341,100 shares $23.34 million +2.8%3.0%8.9 $568.00 2/15/202340,000 shares $27.24 million +2.6%3.0%8.3 $681.10 1/31/202339,000 shares $26.80 million +7.1%2.9%7.2 $687.30 1/15/202336,400 shares $23.01 million -4.2%2.7%6.3 $632.22 12/30/202238,000 shares $21.26 million -11.6%2.8%6.4 $559.45 12/15/202243,000 shares $25.37 million +0.2%3.2%6.8 $590.00 11/30/202242,900 shares $25.95 million -12.1%3.2%7.2 $604.80 11/15/202248,800 shares $30.30 million -4.3%3.6%8.6 $620.93 10/31/202251,000 shares $30.62 million -5.9%3.8%10.4 $600.31 10/15/202254,200 shares $32.18 million +6.3%4.0%13.2 $593.80 9/30/202251,000 shares $28.82 million -16.9%3.8%13.4 $565.00Your $200 account credit is about to expire (Ad)Update to MarketBeat All Access and Save $200 on Your Annual Subscription.Start Your Risk-Free Trial Here 9/15/202261,400 shares $36.99 million -3.6%4.5%18.6 $602.51 8/31/202263,700 shares $38.47 million -0.2%4.7%18.7 $603.95 8/15/202263,800 shares $41.79 million -1.9%4.7%18.2 $655.00 7/31/202265,000 shares $43.93 million +0.5%4.7%17.1 $675.90 7/15/202264,700 shares $41.90 million -1.5%4.7%16.6 $647.60 6/30/202265,700 shares $41.32 million -6.3%4.8%15.6 $628.86 6/15/202270,100 shares $44.79 million +4.5%4.9%17.5 $638.97 5/31/202267,100 shares $42.19 million -0.5%4.9%16.8 $628.79 5/15/202267,400 shares $41.38 million +1.1%4.9%17.3 $614.00 4/30/202266,700 shares $41.80 million +0.5%4.9%15.9 $626.62 4/15/202266,400 shares $48.66 million -3.1%4.9%14.4 $732.88 3/31/202268,500 shares $48.84 million -4.5%5.0%15.2 $713.00 3/15/202271,700 shares $52.91 million +2.6%5.2%14.9 $738.00 2/28/202269,900 shares $50.01 million +3.4%5.1%14 $715.46 2/15/202267,600 shares $44.53 million +6.3%4.9%13.5 $658.69 1/31/202263,600 shares $38.50 million -2.3%4.6%13.3 $605.41 1/15/202265,100 shares $45.08 million -0.5%4.7%14.8 $692.49 12/31/202165,400 shares $46.10 million -3.0%4.7%15.2 $704.90 12/15/202167,400 shares $45.79 million +1.4%4.9%14.7 $679.32 11/30/202166,500 shares $47.21 million -2.8%4.8%13 $709.99 11/15/202168,400 shares $53.50 million +1.9%5.0%12 $782.12 10/29/202167,100 shares $48.85 million -1.2%4.9%10.8 $728.00 10/15/202167,900 shares $45.82 million +0.9%4.9%10.8 $674.81 9/30/202167,300 shares $46.94 million -10.6%4.9%10.4 $697.50 9/15/202175,300 shares $55.66 million +3.2%5.5%11.2 $739.12 8/31/202173,000 shares $50.67 million +12.1%5.3%11.4 $694.06 8/13/202165,100 shares $40.83 million +2.0%4.7%10 $627.20 7/30/202163,800 shares $40.13 million +0.6%4.6%10 $628.94 7/15/202163,400 shares $38.65 million +1.0%4.5%9.6 $609.70 6/30/202162,800 shares $38.99 million -9.3%4.5%9.7 $620.93 6/15/202169,200 shares $43.40 million +1.5%4.9%11 $627.11 5/28/202168,200 shares $42.35 million +4.0%4.9%10 $621.00 5/14/202165,600 shares $39.62 million +2.7%4.6%8 $603.90 4/30/202163,900 shares $41.33 million -2.0%4.5%8.2 $646.80 4/15/202165,200 shares $42.09 million -0.6%N/A0 $645.51 3/31/202165,600 shares $42.35 million -4.0%4.7%8 $645.53 3/15/202168,300 shares $46.79 million +1.3%4.9%7.4 $685.00 2/26/202167,400 shares $43.14 million -1.0%4.8%8.5 $640.00 2/12/202168,100 shares $46.88 million -1.3%4.8%9.2 $688.40 1/29/202169,000 shares $45.70 million +1.3%4.9%9.3 $662.29 1/15/202168,100 shares $48.25 million +8.6%4.8%9.3 $708.55 12/31/202062,700 shares $40.16 million +19.2%4.5%7.8 $640.50 12/15/202052,600 shares $32.78 million -0.2%3.8%6.3 $623.11 11/30/202052,700 shares $31.33 million +1.5%3.8%6.9 $594.41 11/15/202051,900 shares $30.84 million -1.3%3.7%7.5 $594.30 10/30/202052,600 shares $32.19 million +1.0%3.8%7.9 $612.00 10/15/202052,100 shares $33.69 million -8.9%3.7%7.3 $646.57 9/30/202057,200 shares $35.81 million -11.0%4.1%9.7 $626.00 9/15/202064,300 shares $40.57 million -4.2%4.6%11.9 $631.01 8/31/202067,100 shares $42.39 million -0.9%4.8%12.9 $631.72Your $200 account credit is about to expire (Ad)Update to MarketBeat All Access and Save $200 on Your Annual Subscription.Start Your Risk-Free Trial Here 8/14/202067,700 shares $44.02 million -9.9%4.8%12.8 $650.23 7/31/202075,100 shares $46.57 million -3.8%5.4%13.2 $620.10 7/15/202078,100 shares $50.45 million -2.7%5.5%13.7 $646.00 6/30/202080,300 shares $50.83 million -3.1%5.7%13 $633.00 6/15/202082,900 shares $53.89 million +0.9%5.9%12.8 $650.00 5/29/202082,200 shares $52.77 million -1.3%5.8%10.8 $642.00 5/15/202083,300 shares $52.98 million -7.7%5.9%10.4 $635.99 4/30/202090,200 shares $56.99 million -1.1%6.4%11.4 $631.83 4/15/202091,200 shares $61.91 million -3.5%6.4%11.7 $678.79 3/31/202094,500 shares $61.97 million -2.6%6.6%12 $655.76 3/13/202097,000 shares $69.05 million +2.4%6.8%12.3 $711.90 2/28/202094,700 shares $60.61 million -1.0%6.6%13 $640.02 2/14/202095,700 shares $66.93 million +2.8%6.7%13.7 $699.37 1/31/202093,100 shares $58.82 million -5.0%6.5%12.9 $631.80 1/15/202098,000 shares $66.86 million -3.5%6.9%12 $682.20 12/31/2019101,500 shares $73.08 million -7.6%7.1%10.5 $720.03 8/15/2019104,500 shares $79.82 million +31.0%7.4%7.3 $763.81 ATRI Short Interest - Frequently Asked Questions What is Atrion's current short interest? Short interest is the volume of Atrion shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 129,200 shares of ATRI short. 9.50% of Atrion's shares are currently sold short. Learn More on Atrion's current short interest. What is a good short interest ratio for Atrion? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATRI shares currently have a short interest ratio of 5.0. Learn More on Atrion's short interest ratio. What is a good short interest percentage for Atrion? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.50% of Atrion's floating shares are currently sold short. Is Atrion's short interest increasing or decreasing? Atrion saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 129,200 shares, an increase of 7.2% from the previous total of 120,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Atrion's float size? Atrion currently has issued a total of 1,760,000 shares. Some of Atrion's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Atrion currently has a public float of 1,360,000 shares. How does Atrion's short interest compare to its competitors? 9.50% of Atrion's shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Atrion: Anika Therapeutics, Inc. (5.32%), OraSure Technologies, Inc. (6.02%), Cerus Co. (3.25%), Utah Medical Products, Inc. (2.35%), ICU Medical, Inc. (5.42%), Embecta Corp. (5.15%), OrthoPediatrics Corp. (7.14%), Silk Road Medical, Inc (8.70%), Paragon 28, Inc. (11.90%), Artivion, Inc. (7.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Atrion stock? Short selling ATRI is an investing strategy that aims to generate trading profit from Atrion as its price is falling. ATRI shares are trading down $6.88 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Atrion? A short squeeze for Atrion occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATRI, which in turn drives the price of the stock up even further. How often is Atrion's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATRI, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Anika Therapeutics Short Squeeze OraSure Technologies Short Squeeze Cerus Short Squeeze Utah Medical Products Short Squeeze ICU Medical Short Squeeze Embecta Short Squeeze OrthoPediatrics Short Squeeze Silk Road Medical Short Squeeze Paragon 28 Short Squeeze Artivion Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATRI) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWall Street Legend Warns: "A Strange Day Is Coming to America"Chaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atrion Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.